Literature DB >> 11091274

CXC chemokines Gro(alpha)/IL-8 and IP-10/MIG in Helicobacter pylori gastritis.

M Eck1, B Schmausser, K Scheller, A Toksoy, M Kraus, T Menzel, H K Müller-Hermelink, R Gillitzer.   

Abstract

Infection with Helicobacter pylori causes chronic active gastritis, which is characterized by neutrophils infiltrating the gastric epithelial layer and the underlying lamina propria as well as by T, B lymphocytes and macrophages accumulating in the lamina propria. In this study, the chemokine profile responsible for the recruitment of these inflammatory cells is investigated. Using both RNA/RNA in situ hybridization and immunohistochemistry, the expression of the neutrophil and/or lymphocyte-attractant CXC chemokines growth-related oncogene alpha (Gro(alpha)), IL-8, interferon-gamma (IFN-gamma)-inducible protein-10 (IP-10), monokine induced by IFN-gamma (MIG) and the CC chemokines macrophage inflammatory protein-1alpha (MIP-1alpha), -1beta, regulated on activation normal T cell expressed and secreted (RANTES) and monocyte chemoattractant protein-1 (MCP-1) is studied and microanatomically localized in the gastric mucosa. Macrophages in the lamina propria at sites with neutrophil infiltration and gastric epithelium infiltrated by neutrophils highly expressed the neutrophil-attractant chemokines Gro(alpha) and IL-8. Additionally, Gro(alpha) and IL-8 were expressed by neutrophils themselves localized within gastric epithelium, in the foveolar lumen and in the cellular debris overlying mucosal erosion. IP-10 and to a lower extent MIG, both selectively chemotactic for inflammatory T cells, were expressed by endothelial cells of gastric mucosal vessels and by mononuclear cells at sites with T cell infiltration. Expression of all other CC chemokines tested was significantly lower. These in vivo data indicate that a set of predominantly CXC chemokines modulates the inflammation in H. pylori gastritis. Gro(alpha) and IL-8 may play an important role in neutrophil trafficking from the mucosal vessel into the gastric epithelium, whereas IP-10 and MIG contribute to the recruitment of inflammatory T cells into the mucosa.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11091274      PMCID: PMC1905774          DOI: 10.1046/j.1365-2249.2000.01374.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein.

Authors:  M Eck; B Schmausser; R Haas; A Greiner; S Czub; H K Müller-Hermelink
Journal:  Gastroenterology       Date:  1997-05       Impact factor: 22.682

2.  Evaluation of Helicobacter pylori in gastric MALT-type lymphoma: differences between histologic and serologic diagnosis.

Authors:  M Eck; A Greiner; B Schmausser; H Eck; M Kolve; W Fischbach; P Strecker; H K Müller-Hermelink
Journal:  Mod Pathol       Date:  1999-12       Impact factor: 7.842

3.  The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells.

Authors:  A Sauty; M Dziejman; R A Taha; A S Iarossi; K Neote; E A Garcia-Zepeda; Q Hamid; A D Luster
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

4.  Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa.

Authors:  Y Yamaoka; M Kita; T Kodama; N Sawai; J Imanishi
Journal:  Gastroenterology       Date:  1996-06       Impact factor: 22.682

5.  Production of IL-12 in gastritis relates to infection with Helicobacter pylori.

Authors:  J Bauditz; M Ortner; M Bierbaum; G Niedobitek; H Lochs; S Schreiber
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 6.  Mig and IP-10: CXC chemokines that target lymphocytes.

Authors:  J M Farber
Journal:  J Leukoc Biol       Date:  1997-03       Impact factor: 4.962

7.  Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes.

Authors:  M Loetscher; B Gerber; P Loetscher; S A Jones; L Piali; I Clark-Lewis; M Baggiolini; B Moser
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

8.  T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease.

Authors:  M M D'Elios; M Manghetti; M De Carli; F Costa; C T Baldari; D Burroni; J L Telford; S Romagnani; G Del Prete
Journal:  J Immunol       Date:  1997-01-15       Impact factor: 5.422

9.  Chemokine mRNA expression in gastric mucosa is associated with Helicobacter pylori cagA positivity and severity of gastritis.

Authors:  T Shimoyama; S M Everett; M F Dixon; A T Axon; J E Crabtree
Journal:  J Clin Pathol       Date:  1998-10       Impact factor: 3.411

10.  Helicobacter-specific cell-mediated immune responses display a predominant Th1 phenotype and promote a delayed-type hypersensitivity response in the stomachs of mice.

Authors:  M Mohammadi; S Czinn; R Redline; J Nedrud
Journal:  J Immunol       Date:  1996-06-15       Impact factor: 5.422

View more
  35 in total

Review 1.  Activation of type I IFN signaling by NOD1 mediates mucosal host defense against Helicobacter pylori infection.

Authors:  Tomohiro Watanabe; Naoki Asano; Atsushi Kitani; Ivan J Fuss; Tsutomu Chiba; Warren Strober
Journal:  Gut Microbes       Date:  2011 Jan-Feb

2.  Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa.

Authors:  Anna Lundgren; Christina Trollmo; Anders Edebo; Ann-Mari Svennerholm; B Samuel Lundin
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

3.  NOD1 contributes to mouse host defense against Helicobacter pylori via induction of type I IFN and activation of the ISGF3 signaling pathway.

Authors:  Tomohiro Watanabe; Naoki Asano; Stefan Fichtner-Feigl; Peter L Gorelick; Yoshihisa Tsuji; Yuko Matsumoto; Tsutomu Chiba; Ivan J Fuss; Atsushi Kitani; Warren Strober
Journal:  J Clin Invest       Date:  2010-04-12       Impact factor: 14.808

4.  Collaborative Interferon-γ and Interleukin-17 Signaling Protects the Oral Mucosa from Staphylococcus aureus.

Authors:  Jobert G Barin; Monica V Talor; Julie A Schaub; Nicola L Diny; Xuezhou Hou; Matthew Hoyer; Nathan K Archer; Elizabeth S Gebremariam; Meghan F Davis; Lloyd S Miller; Noel R Rose; Daniela Čiháková
Journal:  Am J Pathol       Date:  2016-07-26       Impact factor: 4.307

5.  Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model.

Authors:  Michael Kotiw; Megan Johnson; Manisha Pandey; Scott Fry; Stuart L Hazell; Hans J Netter; Michael F Good; Colleen Olive
Journal:  Clin Vaccine Immunol       Date:  2011-12-28

6.  IFN-gamma synergizes with TNF-alpha but not with viable H. pylori in up-regulating CXC chemokine secretion in gastric epithelial cells.

Authors:  M Kraft; S Riedel; C Maaser; T Kucharzik; A Steinbuechel; W Domschke; N Luegering
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

7.  Inhibitory effects of eupatilin on tumor invasion of human gastric cancer MKN-1 cells.

Authors:  Byeong Bae Park; Jin sun Yoon; Eun shil Kim; Jiyoung Choi; Young woong Won; Jung hye Choi; Young Yiul Lee
Journal:  Tumour Biol       Date:  2013-01-08

8.  Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.

Authors:  Dionyssios N Sgouras; Effrosini G Panayotopoulou; Beatriz Martinez-Gonzalez; Kalliopi Petraki; Spyros Michopoulos; Andreas Mentis
Journal:  Clin Diagn Lab Immunol       Date:  2005-12

9.  Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in Helicobacter pylori infection.

Authors:  B Schmausser; M Andrulis; S Endrich; S K Lee; C Josenhans; H-K Müller-Hermelink; M Eck
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

10.  Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma.

Authors:  M Eck; B Schmausser; K Scheller; S Brändlein; H K Müller-Hermelink
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.